Efficacy and Safety of Spironolactone in Patients With HFpEF and Chronic Kidney Disease.
暂无分享，去创建一个
Akshay S. Desai | Sanjiv J. Shah | S. Solomon | M. Pfeffer | A. Desai | B. Pitt | A. Voors | B. Claggett | J. Fang | P. Myhre | E. O'meara | K. Damman | E. Lewis | I. Beldhuis | E. O’Meara